We found that in CML cells, PTPRG expression inversely correlates with BCR/ABL1 expression and activation, both in cell lines and primary cell models following pathways that include beta catenin [21] and possibly others that are currently under investigation [17,20,21]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.